vs
MARAVAI LIFESCIENCES HOLDINGS, INC.（MRVI）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是MARAVAI LIFESCIENCES HOLDINGS, INC.的1.9倍（$94.3M vs $49.9M），REPUBLIC BANCORP INC净利率更高（24.2% vs -71.6%，领先95.8%），REPUBLIC BANCORP INC同比增速更快（5.3% vs -11.8%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $-24.9M），过去两年REPUBLIC BANCORP INC的营收复合增速更高（-11.5% vs -11.9%）
Maravai生命科学控股是一家全球化生命科学企业，专注于开发供应关键试剂、诊断产品及技术解决方案，服务于生物制药研发、药物开发、临床诊断及细胞和基因疗法制造领域，客户覆盖全球相关科研、医疗和企业机构。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
MRVI vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.9倍
$49.9M
营收增速更快
RBCAA
高出17.1%
-11.8%
净利率更高
RBCAA
高出95.8%
-71.6%
自由现金流更多
RBCAA
多$186.0M
$-24.9M
两年增速更快
RBCAA
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.9M | $94.3M |
| 净利润 | $-35.7M | $22.8M |
| 毛利率 | 25.8% | — |
| 营业利润率 | -117.9% | 29.3% |
| 净利率 | -71.6% | 24.2% |
| 营收同比 | -11.8% | 5.3% |
| 净利润同比 | -37.7% | 20.0% |
| 每股收益（稀释后） | $-0.24 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MRVIRBCAA
| Q4 25 | $49.9M | $94.3M | ||
| Q3 25 | $41.6M | $93.5M | ||
| Q2 25 | $47.4M | $93.8M | ||
| Q1 25 | $46.9M | $135.8M | ||
| Q4 24 | $56.6M | $89.5M | ||
| Q3 24 | $69.0M | $88.1M | ||
| Q2 24 | $69.4M | $86.9M | ||
| Q1 24 | $64.2M | $120.3M |
净利润MRVIRBCAA
| Q4 25 | $-35.7M | $22.8M | ||
| Q3 25 | $-25.6M | $29.7M | ||
| Q2 25 | $-39.6M | $31.5M | ||
| Q1 25 | $-29.9M | $47.3M | ||
| Q4 24 | $-25.9M | $19.0M | ||
| Q3 24 | $-97.1M | $26.5M | ||
| Q2 24 | $-9.8M | $25.2M | ||
| Q1 24 | $-12.1M | $30.6M |
毛利率MRVIRBCAA
| Q4 25 | 25.8% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | 16.5% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 44.4% | — | ||
| Q1 24 | 40.3% | — |
营业利润率MRVIRBCAA
| Q4 25 | -117.9% | 29.3% | ||
| Q3 25 | -98.6% | 40.4% | ||
| Q2 25 | -139.8% | 43.0% | ||
| Q1 25 | -104.9% | 44.1% | ||
| Q4 24 | -66.7% | 25.8% | ||
| Q3 24 | -239.9% | 38.4% | ||
| Q2 24 | -19.4% | 37.0% | ||
| Q1 24 | -29.4% | 32.2% |
净利率MRVIRBCAA
| Q4 25 | -71.6% | 24.2% | ||
| Q3 25 | -61.4% | 31.8% | ||
| Q2 25 | -83.5% | 33.5% | ||
| Q1 25 | -63.9% | 34.8% | ||
| Q4 24 | -45.8% | 21.2% | ||
| Q3 24 | -140.6% | 30.1% | ||
| Q2 24 | -14.1% | 29.0% | ||
| Q1 24 | -18.8% | 25.4% |
每股收益（稀释后）MRVIRBCAA
| Q4 25 | $-0.24 | — | ||
| Q3 25 | $-0.18 | — | ||
| Q2 25 | $-0.27 | — | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.21 | — | ||
| Q3 24 | $-0.68 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.09 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $216.9M | $220.0M |
| 总债务越低越好 | $291.8M | — |
| 股东权益账面价值 | $212.4M | $1.1B |
| 总资产 | $770.6M | $7.0B |
| 负债/权益比越低杠杆越低 | 1.37× | — |
8季度趋势，按日历期对齐
现金及短期投资MRVIRBCAA
| Q4 25 | $216.9M | $220.0M | ||
| Q3 25 | $243.6M | $484.2M | ||
| Q2 25 | $269.9M | $484.8M | ||
| Q1 25 | $285.1M | $793.0M | ||
| Q4 24 | $322.4M | $432.2M | ||
| Q3 24 | $578.2M | $530.9M | ||
| Q2 24 | $573.2M | $400.1M | ||
| Q1 24 | $561.7M | $546.4M |
总债务MRVIRBCAA
| Q4 25 | $291.8M | — | ||
| Q3 25 | $292.8M | — | ||
| Q2 25 | $293.9M | — | ||
| Q1 25 | $294.9M | — | ||
| Q4 24 | $295.9M | — | ||
| Q3 24 | $521.7M | — | ||
| Q2 24 | $522.5M | — | ||
| Q1 24 | $523.3M | — |
股东权益MRVIRBCAA
| Q4 25 | $212.4M | $1.1B | ||
| Q3 25 | $245.4M | $1.1B | ||
| Q2 25 | $265.9M | $1.1B | ||
| Q1 25 | $300.6M | $1.0B | ||
| Q4 24 | $325.3M | $992.0M | ||
| Q3 24 | $344.9M | $979.7M | ||
| Q2 24 | $434.7M | $955.4M | ||
| Q1 24 | $410.7M | $935.6M |
总资产MRVIRBCAA
| Q4 25 | $770.6M | $7.0B | ||
| Q3 25 | $849.2M | $7.0B | ||
| Q2 25 | $897.0M | $7.0B | ||
| Q1 25 | $959.8M | $7.1B | ||
| Q4 24 | $1.0B | $6.8B | ||
| Q3 24 | $1.3B | $6.7B | ||
| Q2 24 | $1.4B | $6.6B | ||
| Q1 24 | $1.4B | $6.9B |
负债/权益比MRVIRBCAA
| Q4 25 | 1.37× | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 0.91× | — | ||
| Q3 24 | 1.51× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 1.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.8M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $-24.9M | $161.1M |
| 自由现金流率自由现金流/营收 | -49.9% | 170.9% |
| 资本支出强度资本支出/营收 | 4.2% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $-70.7M | $288.6M |
8季度趋势，按日历期对齐
经营现金流MRVIRBCAA
| Q4 25 | $-22.8M | $168.2M | ||
| Q3 25 | $-15.2M | $33.3M | ||
| Q2 25 | $-10.3M | $8.4M | ||
| Q1 25 | $-9.4M | $93.2M | ||
| Q4 24 | $-14.6M | $149.0M | ||
| Q3 24 | $13.1M | $51.3M | ||
| Q2 24 | $17.4M | $4.0M | ||
| Q1 24 | $-8.5M | $71.2M |
自由现金流MRVIRBCAA
| Q4 25 | $-24.9M | $161.1M | ||
| Q3 25 | $-18.1M | $30.8M | ||
| Q2 25 | $-13.1M | $5.2M | ||
| Q1 25 | $-14.6M | $91.6M | ||
| Q4 24 | $-20.5M | $143.2M | ||
| Q3 24 | $4.5M | $49.8M | ||
| Q2 24 | $7.9M | $2.7M | ||
| Q1 24 | $-14.1M | $69.1M |
自由现金流率MRVIRBCAA
| Q4 25 | -49.9% | 170.9% | ||
| Q3 25 | -43.4% | 32.9% | ||
| Q2 25 | -27.7% | 5.5% | ||
| Q1 25 | -31.2% | 67.4% | ||
| Q4 24 | -36.2% | 160.0% | ||
| Q3 24 | 6.6% | 56.5% | ||
| Q2 24 | 11.4% | 3.1% | ||
| Q1 24 | -22.0% | 57.5% |
资本支出强度MRVIRBCAA
| Q4 25 | 4.2% | 7.5% | ||
| Q3 25 | 7.0% | 2.6% | ||
| Q2 25 | 6.1% | 3.5% | ||
| Q1 25 | 11.2% | 1.2% | ||
| Q4 24 | 10.3% | 6.5% | ||
| Q3 24 | 12.4% | 1.7% | ||
| Q2 24 | 13.8% | 1.5% | ||
| Q1 24 | 8.8% | 1.7% |
现金转化率MRVIRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
RBCAA
暂无分部数据
